Table 2.
Summary of Current Literature on Intra-Oral Topical Treatment Options.
| Reference | Summary | Drugs Mentioned | Method of Use |
|---|---|---|---|
| [34]. Haribabu et al., 2013 |
Case report on topical medications for managing neuropathic orofacial pain, including various drug combinations. | 4% carbamazepine, 1% lidocaine, 4% gabapentin |
Several weeks of topical treatment |
| [35]. Nasri-Heir et al., 2013 |
Overview of topical medications as a treatment for neuropathic orofacial pain, highlighting their application and benefits. | N/A | N/A |
| [1]. Padilla et al., 2000 |
Review of topical medications for orofacial neuropathic pain, discussing their applications and potential effectiveness. | N/A | N/A |
| [38]. Dworkin et al., 2007 |
Evidence-based recommendations for pharmacologic management of neuropathic pain, including topical options. | N/A | N/A |
| [10]. Baad-Hansen and Benoliel, 2017 |
Discussion of neuropathic orofacial pain, highlighting facts and fiction in its treatment approaches. | N/A | N/A |
| [23]. Heir et al., 2022 |
A narrative review discussing the use of compounded topical medications for orofacial pain treatment. | ketamine 4%, carbamazepine 4%, lidocaine 1%, ketoprofen 4%, gabapentin 4%, and especially pregabalin 5–10% within a lipoderm inert vehicle |
Application beneath neurosensory stent 3 to 4 times per day |
| capsaicin 0.025–0.075% paste or 8% patch |
Up to 4 times a day for 8 weeks 1–4 patches for 30–60 min, once in 3 months |
||
| [41]. Casale et al., 2014 |
Case report on the use of 5% lidocaine-medicated plaster for localized neuropathic orofacial pain. | 5% lidocaine-medicated plaster | Application to affected area |
| [42]. Fusco and Alessandri, 1992 |
Discussion of the analgesic effect of capsaicin in trigeminal neuralgia. | capsaicin | Application to affected area |
| [45]. Bavarian et al., 2022 |
Retrospective case series on the use of oral appliances in the management of neuropathic orofacial pain. | N/A | N/A |
| [46]. Axell, T., 2008 |
Exploration of the treatment of painful symptoms in the oral mucosa using lingual acrylic splints. | N/A | N/A |
| [49]. Patel S et al., 2018 |
Discussion of topical medications for common orofacial pain conditions, emphasizing practical applications. | benzocaine, lidocaine | N/A |
| [50]. Vickers et al., 1998 |
Analysis of patients with atypical odontalgia and pharmacological procedures for diagnosis and treatment. | 0.025% capsaicin for 3 min twice a day after local anesthetic application | Local application for 3 min twice a day after local anesthetic application |
| [37]. Heir et al., 2008 |
Retrospective study on the use of topical medications in orofacial neuropathic pain treatment. | 4% carbamazepine, 1% lidocaine, 4% ketoprofen, 4% ketamine, and 4% gabapentin | Topical application |
| [51]. Plaza-Villegas et al., 2012 |
The only study on an animal model—rats with local neuropathic pain, applying a topical regimen of pregabalin and diclofenac—showing a reduction in pain intensity. | Topical regimen of pregabalin 10% and diclofenac 5%. | Topical application |